| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,937 | 20,813 | 14,816 | 25,495 | | Cost of Revenue | 7,460 | 8,737 | 5,800 | 10,060 | | | Gross Profit | 10,477 | 12,076 | 9,016 | 15,435 | | | Operating Expenses | | Research Development | 1,564 | 1,696 | 1,741 | 1,891 | | Selling General and Administrative | 12,254 | 14,472 | 14,410 | 18,601 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,341) | (4,092) | (7,135) | (5,057) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 496 | 209 | 423 | | Earnings Before Interest And Taxes | (2,887) | (3,596) | (6,926) | (4,634) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,887) | (3,596) | (6,926) | (4,634) | | Income Tax Expense | (972) | (1,272) | (2,905) | (2,141) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,915) | (2,324) | (4,021) | (2,493) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,915) | (2,324) | (4,021) | (2,493) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,915) | ($2,324) | ($4,021) | ($2,493) |
|
0.51% Nasdaq 
Income Statement
